Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 3/2011

01-09-2011 | Original Article

The effects of ozone therapy and coenzyme Q10 combination on oxidative stress markers in healthy subjects

Authors: M. İnal, A. Dokumacioglu, E. Özcelik, O. Ucar

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2011

Login to get access

Abstract

Background

Ozone therapy is employed as a therapeutic agent in various diseases. Since ozone itself is a radical, using a small dosage of it is known to create an oxidative preconditioning in the body and trigger a strong antioxidant response against that. Coenzyme Q10, as a strong antioxidant agent, is delivered as a supportive factor in many diseases involving oxidative stress.

Aim

The aim of the study was to evaluate the effects of the combination treatment over oxidative stress in healthy individuals.

Methods

In the current study, 11 healthy volunteers were administered a combination of ozone therapy and Q10 for 1 month. Blood samples were collected first right after the initial ozone therapy and then 1 month after the ozone therapy + coenzyme Q10 treatment. We measured erythrocyte superoxide dismutase and catalase enzyme activities along with serum malondialdehyde levels.

Results

Compared with the pretreatment values, an increase was determined in the erythrocyte superoxide dismutase and catalase enzyme activities. However, malondialdehyde, an indicator of oxidative membrane damage, showed a reduction after the combination treatment.

Conclusion

The results of this study reveal the beneficial effects of ozone therapy + coenzyme Q10 combination in prevention of oxidative damage.
Literature
1.
go back to reference Merin O, Attias E, Elstein D et al (2007) Ozone administration reduces reperfusion injury in an isolated rat heart model. J Card Surg 22:339–342PubMedCrossRef Merin O, Attias E, Elstein D et al (2007) Ozone administration reduces reperfusion injury in an isolated rat heart model. J Card Surg 22:339–342PubMedCrossRef
2.
go back to reference Hernandez FA, Calunga JL, Turrent J, Mene′ndez Cepero S, Montenegro Perdomo A (2005) Ozone therapy effects on biomarkers and lung function in asthma. Arch Med Res 36:549–554CrossRef Hernandez FA, Calunga JL, Turrent J, Mene′ndez Cepero S, Montenegro Perdomo A (2005) Ozone therapy effects on biomarkers and lung function in asthma. Arch Med Res 36:549–554CrossRef
3.
go back to reference Chen H, Xing B, Liu X et al (2008) Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol 10:306–314CrossRef Chen H, Xing B, Liu X et al (2008) Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol 10:306–314CrossRef
4.
go back to reference Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Zimran A (2001) Ozone enema: a model of microscopic colitis in rats. Dig Dis Sci 46:2515–2520PubMedCrossRef Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Zimran A (2001) Ozone enema: a model of microscopic colitis in rats. Dig Dis Sci 46:2515–2520PubMedCrossRef
5.
go back to reference Bocci V (2007) The case for oxygen-ozonetherapy. Br J Biomed Sci 64(1):44–49PubMed Bocci V (2007) The case for oxygen-ozonetherapy. Br J Biomed Sci 64(1):44–49PubMed
6.
go back to reference Hernández FA (2007) To what extent does ozone therapy need a real biochemical control system? Assessment and importance of oxidative stress. Arch Med Res 38:571–578PubMedCrossRef Hernández FA (2007) To what extent does ozone therapy need a real biochemical control system? Assessment and importance of oxidative stress. Arch Med Res 38:571–578PubMedCrossRef
7.
go back to reference Madej P, Plewka A, Madej JA et al (2007) Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs inevaluation of free radical reactions and selected enzymatic systems. Inflammation 30:52–58PubMedCrossRef Madej P, Plewka A, Madej JA et al (2007) Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs inevaluation of free radical reactions and selected enzymatic systems. Inflammation 30:52–58PubMedCrossRef
8.
go back to reference Ajamieh HH, Berlanga J, Merino N et al (2005) Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl Int 18:604–612PubMedCrossRef Ajamieh HH, Berlanga J, Merino N et al (2005) Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl Int 18:604–612PubMedCrossRef
9.
go back to reference Méndez-Alvarez E, Soto-Otero R, Sánchez-Sellero I, López-Rivadulla LM (1998) In vitro inhibition of catalase activity by cigarette smoke: relevance for oxidative stress. J Appl Toxicol 18:443–448PubMedCrossRef Méndez-Alvarez E, Soto-Otero R, Sánchez-Sellero I, López-Rivadulla LM (1998) In vitro inhibition of catalase activity by cigarette smoke: relevance for oxidative stress. J Appl Toxicol 18:443–448PubMedCrossRef
10.
go back to reference Xing HB, Liu X, Zhan B, Zhou J, Zhu H, Chen Z (2008) Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Chen Arch Med Res 39:169–178 Xing HB, Liu X, Zhan B, Zhou J, Zhu H, Chen Z (2008) Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Chen Arch Med Res 39:169–178
11.
go back to reference Tsuneki H, Sekizaki N, Suzuki T et al (2007) Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells. Eur J Pharmacol 566:1–10PubMedCrossRef Tsuneki H, Sekizaki N, Suzuki T et al (2007) Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells. Eur J Pharmacol 566:1–10PubMedCrossRef
12.
go back to reference Cooke M, Iosia M, Buford T et al (2008) Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J Int Soc Sports Nutr 4:5–8 Cooke M, Iosia M, Buford T et al (2008) Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J Int Soc Sports Nutr 4:5–8
13.
go back to reference Winterborn CC, Hawkins RE, Brain M et al (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341 Winterborn CC, Hawkins RE, Brain M et al (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341
14.
go back to reference Beutler E (1982) Catalase. Manual of biochemical method. Grune and Stratton, New York, pp 105–106 Beutler E (1982) Catalase. Manual of biochemical method. Grune and Stratton, New York, pp 105–106
15.
go back to reference Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef
16.
go back to reference Devesa E, Menendez S, Rodrõguez MM, Gome ZM, Garcõa J (1993) Ozone therapy in ischemic cerebrovascular disease. In: Proceedings of 11th ozone world congress (USA) Ozonein Medicine M-4–10 to M-4–18 Devesa E, Menendez S, Rodrõguez MM, Gome ZM, Garcõa J (1993) Ozone therapy in ischemic cerebrovascular disease. In: Proceedings of 11th ozone world congress (USA) Ozonein Medicine M-4–10 to M-4–18
17.
go back to reference Romero A, Menendez S, Gomez M, Ley J (1993) Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologõa 45:146–148 Romero A, Menendez S, Gomez M, Ley J (1993) Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologõa 45:146–148
18.
go back to reference Menendez S, Iglesias O, Bidot C, Puga R, Carballo A (1995) Application of ozone therapy in children with humoral immunity deficiency. In: International Ozone Association (ed) Proceedings of 12th ozone world congress, ozone in medicine. Lille, pp 271–274 Menendez S, Iglesias O, Bidot C, Puga R, Carballo A (1995) Application of ozone therapy in children with humoral immunity deficiency. In: International Ozone Association (ed) Proceedings of 12th ozone world congress, ozone in medicine. Lille, pp 271–274
19.
go back to reference Bocci V (1996) Ozone as a bioregulator pharmacology and toxicology of ozone therapy today. J Bil Regulat Homeost Agent 10:31–53 Bocci V (1996) Ozone as a bioregulator pharmacology and toxicology of ozone therapy today. J Bil Regulat Homeost Agent 10:31–53
20.
go back to reference León OS, Menéndez S, Merino N et al (1998) Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm 7:289–294PubMedCrossRef León OS, Menéndez S, Merino N et al (1998) Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm 7:289–294PubMedCrossRef
21.
go back to reference Zamora ZB, Borrego A, López OY et al (2005) Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm 24:16–22CrossRef Zamora ZB, Borrego A, López OY et al (2005) Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm 24:16–22CrossRef
22.
go back to reference Al-Dalain SM, Martínez G, Candelario-Jalil E et al (2001) Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res 44:391–396PubMedCrossRef Al-Dalain SM, Martínez G, Candelario-Jalil E et al (2001) Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res 44:391–396PubMedCrossRef
23.
go back to reference González R, Borrego A, Zamora Z et al (2004) Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Mediators Inflamm 13:307–312PubMedCrossRef González R, Borrego A, Zamora Z et al (2004) Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Mediators Inflamm 13:307–312PubMedCrossRef
24.
go back to reference Ajamieh HH, Menéndez S, Martínez-Sánchez G et al (2004) Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia–reperfusion. Liver Int 24:55–62PubMedCrossRef Ajamieh HH, Menéndez S, Martínez-Sánchez G et al (2004) Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia–reperfusion. Liver Int 24:55–62PubMedCrossRef
25.
go back to reference Calunga JL, Zamora ZB, Borrego A et al (2005) Ozone therapy on rats submitted to subtotal nephrectomy: role of antioxidant system. Mediators Inflamm 31:221–227CrossRef Calunga JL, Zamora ZB, Borrego A et al (2005) Ozone therapy on rats submitted to subtotal nephrectomy: role of antioxidant system. Mediators Inflamm 31:221–227CrossRef
26.
go back to reference Bentinger M, Brismar K, Dallner G (2007) The antioxidant role of coenzyme Q. Mitochondrion 7:41–50CrossRef Bentinger M, Brismar K, Dallner G (2007) The antioxidant role of coenzyme Q. Mitochondrion 7:41–50CrossRef
27.
go back to reference Kwong LK, Kamzalov S, Rebrin I et al (2002) Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med 33:627–638PubMedCrossRef Kwong LK, Kamzalov S, Rebrin I et al (2002) Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med 33:627–638PubMedCrossRef
28.
go back to reference Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP (2007) Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 28:2249–2255PubMedCrossRef Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP (2007) Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 28:2249–2255PubMedCrossRef
29.
go back to reference Groneberg DA, Kindermann B, Althammer M et al (2005) Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol 37:1208–1218PubMedCrossRef Groneberg DA, Kindermann B, Althammer M et al (2005) Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol 37:1208–1218PubMedCrossRef
Metadata
Title
The effects of ozone therapy and coenzyme Q10 combination on oxidative stress markers in healthy subjects
Authors
M. İnal
A. Dokumacioglu
E. Özcelik
O. Ucar
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2011
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-011-0675-7

Other articles of this Issue 3/2011

Irish Journal of Medical Science (1971 -) 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.